BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18499685)

  • 1. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings.
    Terada T; Sugiura M
    Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma presenting as a precocious cutaneous metastasis.
    Royer MC; Rush WL; Lupton GP
    Am J Dermatopathol; 2008 Feb; 30(1):77-80. PubMed ID: 18212552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J; Chouvet B; Claudy A; Scoazec JY
    Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomatoid carcinoma of the lung presenting as a cutaneous metastasis.
    Terada T
    J Cutan Pathol; 2010 Apr; 37(4):482-5. PubMed ID: 19602061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical presentation of hepatocellular carcinoma.
    UyBarreta V; Mikesh C; Simmons B; Beech DJ
    South Med J; 2000 May; 93(5):516-9. PubMed ID: 10832956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
    Tanaka S; Hirohashi K; Uenishi T; Yamamoto T; Hamba H; Kubo S; Tanaka H; Shuto T; Ogawa M; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):839-41. PubMed ID: 15143930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma with an unusual neuroendocrine component.
    Yamaguchi R; Nakashima O; Ogata T; Hanada K; Kumabe T; Kojiro M
    Pathol Int; 2004 Nov; 54(11):861-5. PubMed ID: 15533230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoid carcinoma of the pancreas penetrating into the gastric cavity: a case report and literature review.
    Kai K; Nakamura J; Ide T; Masuda M; Kitahara K; Miyoshi A; Noshiro H; Tokunaga O
    Pathol Int; 2012 Jul; 62(7):485-90. PubMed ID: 22726068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma metastatic to the oral mucosa: report of a case with multiple gingival localizations.
    Maiorano E; Piattelli A; Favia G
    J Periodontol; 2000 Apr; 71(4):641-5. PubMed ID: 10807130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of metastatic cutaneous nodules of recurrent hepatocellular carcinoma].
    Cho M; Choi CS; Seo GS; Kim TH; Choi SC; Yun KJ; Kim HC
    Korean J Hepatol; 2007 Jun; 13(2):234-8. PubMed ID: 17585197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous renal cell carcinoma and clear cell hepatocellular carcinoma mimicking metastatic disease.
    Hou TC; Wu CC; Yang CR; Wang J
    Pathol Res Pract; 2010 May; 206(5):342-5. PubMed ID: 19608351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma with mesothelioma-like dissemination.
    Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H
    Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
    Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite components of a hepatocellular carcinoma with distinct immunohistochemical and metastatic features.
    Hu S; Mrak RE; Goldblatt PJ
    Conn Med; 2010 Feb; 74(2):79-83. PubMed ID: 20218042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
    Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
    Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.